David Siffringer

Stock Analyst at Cantor Fitzgerald

(0.53)
# 3,931
Out of 4,339 analysts
7
Total ratings
28.6%
Success rate
-18%
Average return

Stocks Rated by David Siffringer

Aligos Therapeutics
May 21, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $5.74
Upside: +248.43%
PayPay
May 1, 2026
Maintained: Buy
Price Target: $25
Current: $19.62
Upside: +27.45%
Mechanics Bancorp
Apr 10, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $14.39
Upside: +18.14%
Domo, Inc.
Dec 24, 2025
Reiterated: Buy
Price Target: $22
Current: $3.75
Upside: +486.67%
Rezolve AI
Dec 24, 2025
Reiterated: Buy
Price Target: $8
Current: $2.60
Upside: +207.69%
BETA Technologies
Dec 8, 2025
Initiated Coverage: Buy
Price Target: $42
Current: $16.84
Upside: +149.41%